跳至主要内容
临床试验/PACTR201411000939962
PACTR201411000939962已完成未知

Open-label, non-randomised single arm trial to investigate the efficacy of Brincidofovir compared to historic controls for Ebolavirus Disease in an outbreak setting in West Africa.

niversity of Oxford0 个研究点目标入组 140 人开始时间: 2014年11月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 Month(s) 至 99 Year(s)(—)
性别
All

入选标准

  • Male and female patients 2 months of age or older
  • Laboratory confirmed infection with Ebolavirus infection.
  • Women who are lactating must agree to stop breastfeeding (a standard recommendation for all EVD patients)
  • Willingness to use barrier birth control for 3 months after recovery of EVD (a standard recommendation for all EVD patients)
  • For patients 18 years and older: the ability to provide fully informed consent or the provision of consent from the representative of a patient deemed too unwell to comprehend what is being asked of them.
  • For patients under 18 years: consent from a parent or guardian.

排除标准

  • Any underlying disease or condition that, in the opinion of the principal investigator or treating physician, could jeopardize the participant¿s or healthcare workers safety or the participant¿s ability to comply with the protocol requirements
  • Patient unable to take oral IMP (e.g. severe vomiting unresponsive to anti-emetics, unconscious)

研究者

相似试验